Schonfeld Strategic Advisors LLC Adma Biologics, Inc. Call Options Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
274Shares Held
178MCall Options Held
535KPut Options Held
21.2K-
Black Rock Inc. New York, NY18.6MShares$292 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$227 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA13.2MShares$206 Million0.03% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL8.93MShares$140 Million0.03% of portfolio
-
State Street Corp Boston, MA8.06MShares$126 Million0.0% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.08B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...